Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted:
03/23/2018
»Therapeutic Categories: Analgesia/Addiction
Alembic Pharmaceuticals (Reverified 04/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 15 mg/1 mL (NDC 62332-599-25) | Available | ||
| Injection, 30 mg/1 mL (NDC 62332-600-25) | Available | ||
| Injection, 60 mg/2 mL (NDC 62332-601-25) | Available |
Baxter Healthcare (Reverified 03/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Limited Availability, Recovery June 2024 | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Limited Availability, May 2024 | FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container) | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 15 mg/1 mL (NDC 76045-107-10) | Unavailable | Not available at this time; Check wholesaler for inventory | Demand increase for the drug |
| Injection, 30 mg/1 mL (NDC 76045-104-10) | Unavailable | RFID NDC 76045-0209-10 release April 2024; Check wholesaler for inventory | Demand increase for the drug |
| Injection, 60 mg/2 mL (NDC 76045-105-20) | Available | Check wholesaler for inventory | |
| Injection, 15 mg/1 mL (NDC 63323-161-01) | Available | Check wholesaler for inventory | |
| Injection, 30 mg/1 mL (NDC 63323-162-01) | Available | Check wholesaler for inventory. | |
| Injection, 30 mg/1 mL (NDC 63323-162-02) | Available | Check wholesaler for inventory. |
Gland Pharma Limited (Revised 03/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-01) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-01) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-02) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03) | Available | ||
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Available |
Hikma Pharmaceuticals USA, Inc. (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 15 mg/1 mL (NDC 0641-6041-25) | Unavailable | Shortage recovery: TBD | Other |
| Injection, 30 mg/1 mL (NDC 0641-6042-25) | Unavailable | Shortage recovery: TBD | Other |
| Injection, 30 mg/1 mL (NDC 0641-6043-25) | Unavailable | Shortage recovery: TBD | Other |
Hospira, Inc., a Pfizer Company (Revised 02/27/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 15 mg/1 mL (NDC 0409-3793-01) | Limited Availability, 2Q 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Injection, 30 mg/1 mL (NDC 0409-3795-01) | Unavailable, 2Q 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Injection, 60 mg/2 mL (NDC 0409-3796-01) | Unavailable, 3Q 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
Sagent Pharmaceuticals (Revised 03/06/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 15 mg/1 mL (NDC 25021-700-01) | Available | ||
| Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | ||
| Injection, 30 mg/1 mL (NDC 25021-701-01) | Available |